• Citer

Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia.

par Afdhal, Nezam;Giannini, Edoardo G;Tayyab, Ghias;Mohsin, Aftab;Lee, Jin-Woo;Andriulli, Angelo;Jeffers, Lennox;McHutchison, John G;Chen, Pei-Jer;Han, Kwang-Hyub;Campbell, Fiona;Hyde, Denise;Brainsky, Andres;Theodore, Dickens;Moreno, Christophe
Référence The New England journal of medicine, 367, 8, page (716-724)
Publication Publié, 2012-08

Article révisé par les pairs

• Détails
• Contenu

Résumé :

Eltrombopag is an oral thrombopoietin-receptor agonist. This study evaluated the efficacy of eltrombopag for increasing platelet counts and reducing the need for platelet transfusions in patients with thrombocytopenia and chronic liver disease who are undergoing an elective invasive procedure.